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A B S T R A C T
Disseminated neonatal herpes simplex virus infection usually presents with multi-organ involvement.
Untreated, this disease has a mortality rate of approximately 80%. Here, we describe a well-appearing 3-
week old infant with isolated compensated hepatic failure caused by HSV-2.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Contents lists available at ScienceDirect
IDCases
jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ idc rIntroduction
Neonatal herpes simplex virus (HSV) infection manifests either
as skin, eye, mouth (SEM) disease, central nervous system (CNS)
disease, or disseminated disease. Disseminated neonatal HSV
infection characteristically presents as a sepsis syndrome with
fever, hepatitis, and pneumonia with or without encephalitis.
Untreated, the mortality rate for disseminated HSV infection
approaches 80% [1]. Prompt diagnosis and early initiation with
antiviral therapy can be life-saving, but early recognition of the
infection is difﬁcult in infants with non-speciﬁc symptoms. We
present a 3-week old infant whose clinical presentation of
disseminated HSV-2 infection included only compensated hepatic
failure.
Case presentation
A 37-week gestation male was born via cesarean section to a
23-year old primigravida mother. The pregnancy was uncompli-
cated. Serologic screening was negative for human immunodeﬁ-
ciency virus and hepatitis B and showed immunity to rubella. At 30
weeks gestation, as per standard of care at the mother’s obstetrics
practice, serologic testing for HSV-1 and HSV-2 IgG were obtained
and were negative. At 35 weeks, vaginal swabs for Group B
streptococcus were negative. The mother had a non-speciﬁc febrile* Corresponding author. Tel.: +1 315 464 6331; fax: +1 315 464 7564.
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2214-2509/ 2014 The Authors. Published by Elsevier Ltd. This is an open access article uillness at 35 weeks gestation that self-resolved, but never had
symptomatic genital herpes.
The patient was born at 37 weeks gestation via cesarean section
due to failure to progress, with APGAR scores of 8 and 9 at 1 and
5 min, respectively. There was no documentation of prolonged
rupture of membranes in the medical records. No fetal scalp
monitoring was used during labor or delivery. He had a normal
newborn physical exam and was discharged home from the
newborn nursery with the mother in good clinical condition.
On day of life 21, he was noted to have poor weight gain and
jaundice and was hospitalized for evaluation. He did not have
fevers, respiratory symptoms, irritability, lethargy, vomiting,
diarrhea, or change in appetite. At the time of hospital admission,
he was well-appearing, with jaundice and hepatomegaly being the
only remarkable ﬁndings on physical exam. Initial laboratory
evaluation revealed an aspartate aminotransferase (AST) concen-
tration of 130 U/L, alanine aminotransferase (ALT) concentration of
141 U/L, gamma-glutamyl transpeptidase (GGT) of 141 U/L, total
bilirubin of 13.6 mg/dL, direct bilirubin of 10.8 mg/dL, and albumin
of 1.9 g/dL. Coagulation studies revealed a prothrombin time (PT)
of 18.8 s and an international normalized ratio (INR) of 1.51. A
complete blood count was normal. Abdominal ultrasound showed
hepatomegaly with extensive punctate calciﬁcations, splenomeg-
aly, and ascites. An infectious work up directed at hepatotropic
organisms was then pursued.
Cerebrospinal ﬂuid (CSF) studies demonstrated 77 white blood -
cells/mm3, with 24% polymorphonuclear cells and 76% mononuclear
cells, 23,500 red blood cells/mm3, glucose of 32 mg/dl, and protein
of 51 mg/dl. Bacterial studies of the blood, cerebrospinal ﬂuid, and
urine were negative. Virologic evaluation including serologies fornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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chain reaction (PCR) for parvovirus from blood as well as
adenovirus, cytomegalovirus, Epstein–Barr virus, varicella zoster
virus, human herpes virus 6, and enterovirus from the cerebro-
spinal ﬂuid, and a urine culture for cytomegalovirus were all
negative. However, herpes simplex virus (HSV) PCR of orophar-
ynx, conjunctiva, and CSF, and rectal culture were all positive for
HSV type 2. Subsequent work-up for disseminated HSV infection
with central nervous system involvement included a computed
tomography (CT) of the brain, hearing evaluation using auditory
brainstem response, and ophthalmologic exam, all of which were
within normal limits.
Treatment with intravenous acyclovir was initiated on hospital
day 2. Repeat HSV PCR from CSF on day 19 of treatment was
negative. During his hospitalization, ursodeoxycholic acid, albu-
min, and furosemide were given for treatment of hyperbilirubi-
nemia and edema, respectively. The patient’s clinical status and
laboratory values remained stable during hospitalization and he
was discharged home after completion of three weeks of
intravenous acyclovir. Upon discharge, he was started on oral
acyclovir suppressive therapy.
At his follow-up visit, four months after discharge, the patient
was thriving, with resolving hepatomegaly, normal laboratory
evaluation, including transaminases, hepatic function, and coagu-
lation studies, and normal neurodevelopment. Repeat maternal
serologic testing for HSV type 2 IgG was also positive. Upon further
questioning, the mother disclosed having sexual contact with a
partner known to have HSV during the last two months of her
pregnancy.
Discussion
Neonatal HSV infection, a potentially devastating disease with a
high rate of morbidity and mortality, occurs between 1/12,500 and
1/1700 live births in the United States [2]. Neonatal HSV infection
is divided into three general classiﬁcations: SEM disease, CNS
disease, and disseminated disease.
SEM disease accounts for 45% of neonatal HSV cases, with
infection limited to skin vesicles, involvement of the eye, and/or
oral mucosa. CNS disease accounts for 30% of neonatal HSV
cases. Approximately two thirds of these babies will also have
skin lesions, although these lesions may not be present early in
disease process. While neonates with SEM disease most often
present between the ﬁrst and second week of life, those with
CNS disease present between the second and third weeks of
life [3].
Disseminated HSV infection, typically presenting during the
ﬁrst two weeks of life, accounts for approximately 25% of
neonatal HSV cases and is the most lethal of the disease
classiﬁcations. Disseminated infection most commonly involves
the liver, adrenal glands, respiratory tract, and central nervous
system. Thus, neonates with disseminated infection may present
with fever, hypothermia, hepatitis, respiratory distress, dissem-
inated intravascular coagulation (DIC), shock, seizures, and/or
encephalitis [2,4,5]. Almost half of these babies will not have
any skin lesions present, making early diagnosis of HSV infection
more elusive. Without antiviral therapy, mortality from dissem-
inated HSV infection is approximately 80% [1]. Here, we describe
an unusual case of a 3 week old baby whose presenting
symptoms of disseminated neonatal HSV-2 infection with
central nervous system involvement included only jaundice
and poor weight gain. Despite the biochemical ﬁndings of
meningitis, the infant never demonstrated overt neurologic
symptoms. Absence of neurologic signs and symptoms, andnormal neuroimaging with the excellent developmental out-
come also suggest absence of encephalitis.
Previously published cases have also described disseminated
neonatal HSV infection presenting with fulminant liver failure.
White presented a febrile 10-day old infant born to a mother with
no history of HSV who was found to have transaminitis, CSF
pleocytosis, and HSV 2 detected by CSF PCR. He received 4 weeks of
intravenous acyclovir with clinical and laboratory improvement
[6]. Abuhasna describes a 4-day old baby boy born to a mother with
no history of HSV who presented with fever, lethargy, respiratory
distress and was found to have fulminant hepatic failure and HSV-
2 detected by CSF PCR. He was treated with 6 weeks of intravenous
acyclovir, due to herpetic relapses after discontinuation of the
antiviral medication, with ultimate clinical and laboratory
improvement [7]. Similarly, Greenes presented a case of dissemi-
nated HSV-2 infection in a full term 6-day old female infant born to
a mother with no history of HSV who was ill-appearing with fever,
vomiting, and hepatomegaly. She went on to develop fulminant
hepatic failure and respiratory arrest on day of life 35 [8]. Contrary
to the febrile, lethargic, ill appearing neonates described in these
previously published reports, our patient with disseminated HSV
infection was afebrile, well-appearing, with isolated compensated
liver failure.
Neonatal HSV infection is typically acquired through expo-
sure to infected maternal genital secretions during delivery. The
risk of acquiring neonatal infection is inﬂuenced by several
factors, including the type of maternal infection and maternal
antibody status, as well as prolonged rupture of membranes
and the use of fetal scalp monitoring [9,10]. Infants born to
women who have a ﬁrst episode genital HSV infection near term
are at a much greater risk of developing neonatal HSV infection
when compared to mothers with a history of recurrent HSV
infection [11]. Similar to the cases mentioned, our patient
was also born to a mother with no history of HSV infection.
Maternal serologic testing at 30 weeks gestation were negative
for HSV and repeat testing 4 weeks post-partum were positive
for HSV-2, ﬁndings consistent with a primary HSV infection near
term.
Treatment for neonatal HSV infection requires intravenous
acyclovir (60 mg/kg/day in three divided doses) for 14 days for SEM
disease, and for a minimum of 21 days for CNS disease or
disseminated disease [3]. Early initiation of appropriate antiviral
therapy has signiﬁcantly reduced mortality from disseminated
HSV infection to approximately 30% [1].
Conclusion
Early administration of antiviral therapy is effective in reducing
morbidity and mortality. It is therefore important to maintain a
high level of suspicion of HSV infection in neonates with evidence
of liver injury, regardless of maternal history of HSV, even in the
absence of other symptoms.
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